Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Rheumatoid Arthritis
  • Spondyloarthritis
Type
Interventional
Phase
Not Applicable
Design
Allocation: RandomizedIntervention Model: Factorial AssignmentMasking: None (Open Label)Masking Description: no maskingPrimary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 80 years
Gender
Both males and females

Description

Selection and inclusion of patients will be done by principal investigator of Rheumatology Department. After verification of inclusion and non-inclusion criteria by principal investigator and signature of consent, patients will be randomized by 1: 1 randomization (centralized randomization by statis...

Selection and inclusion of patients will be done by principal investigator of Rheumatology Department. After verification of inclusion and non-inclusion criteria by principal investigator and signature of consent, patients will be randomized by 1: 1 randomization (centralized randomization by statistician into 2 groups at M0) : Experimental group (individual and group therapeutic education ) M0 (individual) Educational diagnosis and biotherapy education: "subcutaneous injection education" and "biotherapy management". M3 (group with 3 to 10 patients) Intensification Biotherapy Education: Workshops : "Subcutaneous injection education" and "biotherapy management". M6 (individual presential or by phone) Assessment of security skills and questionnaires. M12 (individual presential or by phone) Assessment of security skills and questionnaires. Control group (individual therapeutic education alone ) : M0 (individual) Educational diagnosis and biotherapy education: "subcutaneous injection education" and "biotherapy management". M3 (individual) Intensification Biotherapy Education: "Subcutaneous injection education" and "biotherapy management". M6 (individual présential or by phone) Assessment of security skills and questionnaires. M12 (individual présential or by phone) Assessment of security skills and questionnaires. Group session proposed.

Tracking Information

NCT #
NCT03838939
Collaborators
French Society of Rheumatology
Investigators
Principal Investigator: Françoise FAYET University Hospital, Clermont-Ferrand